CD45 Engagement Induces L‐Selectin Down‐Regulation

DOI Web Site Web Site 被引用文献4件

抄録

<jats:p>The CD45 glycoprotein isoforms exhibit a receptor‐like composition and display intracellular protein tyrosine phosphatase (PTPase) activity. The present study links CD45 to the regulation of L‐selectin (CD62L), a leucocyte glycoprotein important for extravasation and homotypic aggregation. Monoclonal antibodies (MoAbs) IOL1b and AICD45.2, but not GAP8.3, all of which are directed against common CD45 epitopes, were found to elicit lymphocyte L‐selectin down‐regulation. Lymphocyte L‐selectin down‐regulation in response to anti‐CD45 MoAbs was enhanced by high cell density and partially antagonized by the protein tyrosine kinase (PTK) inhibitor, herbimycin A. The MoAbs IOL1b, AICD45.2 and GAP8.3 recognized granulocyte‐expressed CD45 but did not induce loss of L‐selectin expression of granulocytes. In contrast, the CD45 PTPase inhibitor, vanadate, induced L‐selectin down‐regulation both in lymphocytes and granulocytes. The PTPase activation by nitric oxide (NO) or the NO‐generating compound, sodium nitroprusside, did not affect L‐selectin surface expression. Increased concentrations of soluble L‐selectin were detected after anti‐CD45 or vanadate‐induced down‐regulation of L‐selectin surface expression. While activation of protein kinase C (PKC) by phorbol 12‐myristate 13‐acetate (PMA) induces rapid L‐selectin down‐regulation of L‐selectin surface expression in both lymphocytes and granulocytes, the PKC inhibitor, H 7, was also found to down‐regulate lymphocyte and granulocyte L‐selectin surface expression. The inhibitor H 7 synergized with vanadate in down‐regulating lymphocyte L‐selectin surface expression, but partially inhibited vanadate‐induced granulocyte L‐selectin down‐regulation. The results suggest that in a cell type‐specific fashion the PKC system and tyrosine phosphorylation and dephosphorylation cascades are involved in the regulation of L‐selectin surface expression.</jats:p>

収録刊行物

被引用文献 (4)*注記

もっと見る

キーワード

詳細情報 詳細情報について

問題の指摘

ページトップへ